Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 282


Evaluation of human enterovirus 71 and coxsackievirus A16 specific immunoglobulin M antibodies for diagnosis of hand-foot-and-mouth disease.

Yu N, Guo M, He SJ, Pan YX, Chen XX, Ding XX, Hao W, Wang YD, Ge SX, Xia NS, Che XY.

Virol J. 2012 Jan 11;9:12. doi: 10.1186/1743-422X-9-12.


Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.

Wang C, You A, Tian X, Zhao M, Chen Y, Lin T, Zheng J, Xiao M, Zhang Y, Kuang L, Zhou Z, Zhu B.

Virus Res. 2013 Sep;176(1-2):33-6. doi: 10.1016/j.virusres.2013.04.015. Epub 2013 May 21.


Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008.

Zhu Z, Zhu S, Guo X, Wang J, Wang D, Yan D, Tan X, Tang L, Zhu H, Yang Z, Jiang X, Ji Y, Zhang Y, Xu W.

Virol J. 2010 Nov 4;7:300. doi: 10.1186/1743-422X-7-300.


Development of a multiplex polymerase chain reaction assay for simultaneous identification of human enterovirus 71 and coxsackievirus A16.

Thao NT, Ngoc NT, Tú PV, Thúy TT, Cardosa MJ, McMinn PC, Phuektes P.

J Virol Methods. 2010 Dec;170(1-2):134-9. doi: 10.1016/j.jviromet.2010.09.017. Epub 2010 Sep 21.


The development and application of the two real-time RT-PCR assays to detect the pathogen of HFMD.

Cui A, Xu C, Tan X, Zhang Y, Zhu Z, Mao N, Lu Y, Xu W.

PLoS One. 2013 Apr 18;8(4):e61451. doi: 10.1371/journal.pone.0061451. Print 2013.


Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010.

He SJ, Han JF, Ding XX, Wang YD, Qin CF.

Int J Infect Dis. 2013 Nov;17(11):e1025-30. doi: 10.1016/j.ijid.2013.04.003. Epub 2013 Jun 18.


Development of an IgM-capture ELISA for Coxsackievirus A16 infection.

Xu F, He D, He S, Wu B, Guan L, Niu J, Li L, Li C, Weng Z, Yan Q, Yang L, Ge S, Cheng T, Chen Y, Zhang J, Xia N.

J Virol Methods. 2011 Jan;171(1):107-10. doi: 10.1016/j.jviromet.2010.10.009. Epub 2010 Oct 21.


Expression of enterovirus 71 capsid protein VP1 in Escherichia coli and its clinical application.

Shi M, Zhou Y, Cao L, Ding C, Ji Y, Jiang Q, Liu X, Li X, Hou X, Peng H, Shi W.

Braz J Microbiol. 2014 Mar 10;44(4):1215-22. doi: 10.1590/S1517-83822014005000016. eCollection 2013 Dec.


Development and evaluation of rapid point-of-care tests for detection of Enterovirus 71 and Coxsackievirus A16 specific immunoglublin M antibodies.

Zhang J, Weng Z, Du H, Xu F, He S, He D, Cheng T, Zhang J, Ge S, Xia N.

J Virol Methods. 2016 May;231:44-7. doi: 10.1016/j.jviromet.2016.01.015. Epub 2016 Feb 18.


Cross-reactivity of anti-EV71 IgM and neutralizing antibody in series sera of patients infected with Enterovirus 71 and Coxsackievirus A 16.

Lin Y, Wen K, Pan Y, Wang Y, Che X, Wang B.

J Immunoassay Immunochem. 2011;32(3):233-43. doi: 10.1080/15321819.2011.559297.


Improved detection limit in rapid detection of human enterovirus 71 and coxsackievirus A16 by a novel reverse transcription-isothermal multiple-self-matching-initiated amplification assay.

Ding X, Nie K, Shi L, Zhang Y, Guan L, Zhang D, Qi S, Ma X.

J Clin Microbiol. 2014 Jun;52(6):1862-70. doi: 10.1128/JCM.03298-13. Epub 2014 Mar 19.


[The early diagnosis value of EV 71 IgM class antibodies in the hand, foot and mouth disease].

Zhao J, Xu J, Chen WW, Li YL, Tang Y, Li J, Wang HB, Guo TS, Zhao M, Li BA, Mao YL.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Apr;25(2):140-2. Chinese.


[Epidemiological investigation of hand-foot-and-mouth disease in children and exposed population in Hangzhou city].

Zhou J, Wu YD, Chen XL, Song C, Yan J.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Mar;43(2):212-7. Chinese.


Protein microarray-mediated detection of antienterovirus antibodies in serum.

Zhang A, Xiu B, Zhang H, Li N.

J Int Med Res. 2016 Apr;44(2):287-96. doi: 10.1177/0300060515604981. Epub 2016 Feb 1.


A new factor influencing pathogen detection by molecular assay in children with both mild and severe hand, foot, and mouth disease.

Zhu D, Zhao XY, Yao Y, Dai FF, He H, Li RQ, Jin RH, Liang LC, Li N.

Diagn Microbiol Infect Dis. 2013 Jun;76(2):162-7. doi: 10.1016/j.diagmicrobio.2013.02.011. Epub 2013 Mar 25.


Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.

Sun S, Jiang L, Liang Z, Mao Q, Su W, Zhang H, Li X, Jin J, Xu L, Zhao D, Fan P, An D, Yang P, Lu J, Lv X, Sun B, Xu F, Kong W, Jiang C.

Hum Vaccin Immunother. 2014;10(10):2885-95. doi: 10.4161/hv.29823.


Simultaneously typing nine serotypes of enteroviruses associated with hand, foot, and mouth disease by a GeXP analyzer-based multiplex reverse transcription-PCR assay.

Hu X, Zhang Y, Zhou X, Xu B, Yang M, Wang M, Zhang C, Li J, Bai R, Xu W, Ma X.

J Clin Microbiol. 2012 Feb;50(2):288-93. doi: 10.1128/JCM.05828-11. Epub 2011 Nov 23.


Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM.

Morgan-Capner P, McSorley C.

J Hyg (Lond). 1983 Jun;90(3):333-49.

Supplemental Content

Support Center